Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2026-05-17 @ 3:00 AM
Study NCT ID:
NCT07290894
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-18
First Post:
2025-11-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab Plus Lenvatinib in Vulvar Cancer Patients: MITO VULVA-01
Sponsor:
National Cancer Institute, Naples
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MITO VULVA-01 2023-5091802400
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None